FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Oxazepam Capsules
Status: Discontinuation
»Therapeutic Categories:

Expand all

Sandoz (New 09/02/2016)

Company Contact Information:
800-525-8747

Presentation Posting Date Related Information
Oxazepam Capsules 10 mg 100 count (NDC 0781-28-0901) N/A Sandoz Inc. has made a business decision to permanently discontinue Oxazepam Capsules 10 mg, 15 mg, and 30 mg in 100 count bottles. This decision was not related to efficacy, safety, or quality. Oxazepam Capsules 10 mg will be available until approximately October 2016. Oxazepam Capsules 15 mg, and 30 mg will be available until approximately March 2017. Generic equivalents are available
Oxazepam Capsules 15 mg 100 count (NDC 0781-28-1001) N/A Sandoz Inc. has made a business decision to permanently discontinue Oxazepam Capsules 10 mg, 15 mg, and 30 mg in 100 count bottles. This decision was not related to efficacy, safety, or quality. Oxazepam Capsules 10 mg will be available until approximately October 2016. Oxazepam Capsules 15 mg, and 30 mg will be available until approximately March 2017. Generic equivalents are available
Oxazepam Capsules 30 mg 100 count (NDC 0781-28-1101) N/A Sandoz Inc. has made a business decision to permanently discontinue Oxazepam Capsules 10 mg, 15 mg, and 30 mg in 100 count bottles. This decision was not related to efficacy, safety, or quality. Oxazepam Capsules 10 mg will be available until approximately October 2016. Oxazepam Capsules 15 mg, and 30 mg will be available until approximately March 2017. Generic equivalents are available

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English